Nexgel Inc
NASDAQ:NXGL

Watchlist Manager
Nexgel Inc Logo
Nexgel Inc
NASDAQ:NXGL
Watchlist
Price: 4.73 USD 2.38%
Market Cap: 35.6m USD
Have any thoughts about
Nexgel Inc?
Write Note

Nexgel Inc
Other Current Assets

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Nexgel Inc
Other Current Assets Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Other Current Assets CAGR 3Y CAGR 5Y CAGR 10Y
Nexgel Inc
NASDAQ:NXGL
Other Current Assets
$400k
CAGR 3-Years
137%
CAGR 5-Years
12%
CAGR 10-Years
N/A
Haemonetics Corp
NYSE:HAE
Other Current Assets
$61m
CAGR 3-Years
12%
CAGR 5-Years
12%
CAGR 10-Years
-1%
ICU Medical Inc
NASDAQ:ICUI
Other Current Assets
$75.8m
CAGR 3-Years
6%
CAGR 5-Years
21%
CAGR 10-Years
20%
Align Technology Inc
NASDAQ:ALGN
Other Current Assets
$290.7m
CAGR 3-Years
23%
CAGR 5-Years
86%
CAGR 10-Years
21%
Lantheus Holdings Inc
NASDAQ:LNTH
Other Current Assets
$29.2m
CAGR 3-Years
34%
CAGR 5-Years
42%
CAGR 10-Years
21%
Merit Medical Systems Inc
NASDAQ:MMSI
Other Current Assets
$31.3m
CAGR 3-Years
12%
CAGR 5-Years
8%
CAGR 10-Years
10%
No Stocks Found

Nexgel Inc
Glance View

Market Cap
35.6m USD
Industry
Health Care

NexGel, Inc. engages in the manufacture of polymer hydrogels used for wound care, medical diagnostics, transdermal drug delivery, and cosmetics. The company is headquartered in Langhorne, Pennsylvania. The company went IPO on 2021-12-22. The firm is engaged in the manufactures of high-water content, electron beam cross-linked, aqueous polymer hydrogels, or gels, used for wound care, medical diagnostics, transdermal drug delivery and cosmetics. The firm specializes in custom gels by capitalizing on manufacturing technologies. Its products are manufactured by using proprietary and non-proprietary mixing, coating and cross-linking technologies. The company operates as a contract manufacturer of aqueous polymer hydrogels. The company delivers medication through hydrogel patches. Its Hydrogel patches are used for transdermal applications, such as hormone replacement therapy and contraception, treatment of acne, shingles, diabetes, motion sickness, treatment of angina with nitroglycerin and treatment of smoking addiction.

NXGL Intrinsic Value
7.66 USD
Undervaluation 38%
Intrinsic Value
Price

See Also

What is Nexgel Inc's Other Current Assets?
Other Current Assets
400k USD

Based on the financial report for Dec 31, 2023, Nexgel Inc's Other Current Assets amounts to 400k USD.

What is Nexgel Inc's Other Current Assets growth rate?
Other Current Assets CAGR 5Y
12%

Over the last year, the Other Current Assets growth was 135%. The average annual Other Current Assets growth rates for Nexgel Inc have been 137% over the past three years , 12% over the past five years .

Back to Top